Lymphatic filariasis: New insights and prospects for control

Current Opinion in Infectious Diseases

Volumn 14, Issue 5, 2001, Pages 539-546

  Nutman, Thomas B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; DIETHYLCARBAMAZINE; IVERMECTIN; UMF 078; UNCLASSIFIED DRUG;

BRUGIA; FILARIASIS; HUMAN; IMMUNE RESPONSE; LYMPHOID TISSUE; PARASITE CONTROL; PATHOGENESIS; PATHOLOGY; PROPHYLAXIS; REVIEW; WOLBACHIA; WUCHERERIA BANCROFTI;

EID: 0034809482     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200110000-00006     Document Type: Review

References (126)

1. The population dynamics and epidemiology of lymphatic filariasis
2. The clinical manifestations of lymphatic filariasis
3. Renal abnormalities in microfilaremic patients with bancroftian filariasis
4. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis
5. Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis
6. Advances in imaging of lymph flow disorders
7. Pathogenesis of lymphatic disease in bancroftian filariasis: A clinical perspective
8. Reaching maturity: 25 Years of the TDR
9. Development of a serum-free system for the in vitro cultivation of Brugia malayi infective-stage larvae
10. Investigating development of infective stage larvae of filarial nematodes
11. The filarial genome project: Analysis of the nuclear, mitochondrial and endosymbiont genomes of Brugia malayi
12. Influence of intercodon and base frequencies on codon usage in filarial parasites
13. Parasite genome initiatives
14. Two microsatellite loci from Brugia malayi show polymorphisms among isolates from Indonesia and Malaysia
15. Chitin synthase in the filarial parasite, Brugia malayi
16. Identification and localization of glutathione S-transferase as a potential target enzyme in Brugia species
17. The serpin secreted by Brugia malayi microfilariae, Bm-SPN-2, elicits strong, but short-lived, immune responses in mice and humans
18. A 43-kDa circulating filarial antigen fraction of Wuchereria bancrofti in immunoprophylaxis against Brugia malayi in jirds
19. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis
20. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing
21. Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi
22. Epithelial cells release proinflammatory cytokines and undergo c-Myc-induced apoptosis on exposure to filarial parasitic sheath protein-Bcl2 mediates rescue by activating c-H-Ras
23. Upregulation of a raf kinase and a DP-1 family transcription factor in epidermal growth factor (EGF) stimulated filarial parasites
24. Intracytoplasmic bacteria in Onchocerca volvulus
25. Micro-organisms in filarial larvae (Nematoda)
26. Current status and future prospects of the Global Lymphatic Filariasis Programme
27. Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment
28. A phylogenetic analysis of filarial nematodes: Comparison with the phylogeny of Wolbachia endosymbionts
29. Wolbachia bacteria of filarial nematodes: A target for control?
30. Antibiotics and Wolbachia in filarial nematodes: Antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi
31. Wolbachia bacteria of filarial nematodes in the pathogenesis of disease and as a target for control
32. Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: Comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin
33. wsp gene sequences from the Wolbachia of filarial nematodes
34. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria
35. Determination of Wolbachia genome size by pulsed-field gel electrophoresis
36. The silent burden of sexual disability associated with lymphatic filariasis
37. The burden of hydrocele on men in Northern Ghana
38. Genital manifestations and reproductive health in female residents of a Wuchereria bancrofti-endemic area in Tanzania
39. Effect of lymphatic filariasis on school children
40. The economic burden of lymphatic filariasis in India
41. The economic burden of lymphatic filariasis in northern Ghana
42. Lymphatic filariasis in Ghana: From research to control
43. Lymphatic filariasis: Economic aspects of the disease and programmes for its elimination
44. New insights into the natural history and pathology of bancroftian filariasis: Implications for clinical management and filariasis control programmes
45. Skin changes in filarial and non-filarial lymphoedema of the lower extremities
46. Treatment of lymphatic filariasis
47. Immunology of lymphatic filariasis: Current controversies
48. Are inflammation and immunological hyperreactivity necessary for filarial parasite development?
49. Human bancroftian filariasis: Loss of patent microfilaraemia is not associated with production of antibodies to microfilarial sheath
50. Transmission intensity determines lymphocyte responsiveness and cytokine bias in human lymphatic filariasis
51. Diminished expression of the costimulatory ligand CD80 (B7.1) gene correlates with antigen-specific cellular unresponsiveness in rhesus monkeys with lymphatic filariasis
52. NO contributes to proliferative suppression in a murine model of filariasis
53. Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell-to-cell contact
54. Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naive CD4(+) T cells
55. Reciprocal immunomodulatory effects of gamma interferon and interleukin-4 on filaria-induced airway hyperresponsiveness
56. Requirements for in vivo IFN-gamma induction by live microfilariae of the parasitic nematode, Brugia malayi
57. Litomosoides sigmodontis in mice: Reappraisal of an old model for filarial research
58. B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites
59. Role of B lymphocytes in host protection against the human filarial parasite, Brugia malayi
60. Role of gamma interferon and interleukin-4 in host defense against the human filarial parasite Brugia malayi
61. Drastic reduction of a filarial infection in eosinophilic interleukin-5 transgenic mice
62. The third-stage larva (L3) of Brugia: Its role in immune modulation and protective immunity
63. Of filariasis, mice and men
64. Human antibody responses to Wuchereria bancrofti infective larvae
65. Human bancroftian filariasis: A role for antibodies to parasite carbohydrates
66. Protective immunity in human bancroftian filariasis: Inverse relationship between antibodies to microfilarial sheath and circulating filarial antigens
67. Evolution of immunologic responsiveness of persons living in an area of endemic bancroftian filariasis: A 17-year follow-up
68. Antibodies to microfilarial sheath in Bancroftian filariasis: Prevalence and characterization
69. Course of Brugia malayi infection in C57BL/6J NOS2 +/+ and -/- mice
70. Apparent failure of ultrasonography to detect adult worms of Brugia malayi
71. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian filariasis
72. The ICT filariasis test: A rapid format antigen test for diagnosis of bancroftian filariasis
73. The Wuchereria bancrofti orthologue of Brugia malayi SXP1 and the diagnosis of bancroftian filariasis
74. A recombinant antigen-based IgG4 ELISA for the specific and sensitive detection of Brugia malayi infection
75. Rapid PCR-based detection of Brugia malayi DNA from blood spots by DNA detection test strips
76. Sensitivity of the nested-polymerase chain reaction (PCR) assay for Brugia malayi and significance of 'free' DNA in PCR-based assays
77. Detection of DNA of nocturnally periodic Brugia malayi in night and day blood samples by a polymerase chain reaction-ELISA-based method using an internal control DNA
78. Evaluation of PCR-based methods for the diagnosis of infection in bancroftian filariasis
79. Breast filariasis: A case report
80. Filaria in an axillary lymph node dissection specimen
81. A 60 year old woman with axillary mass. Diagnosis: Axillary lymphadenitis: Filarial
82. Coexistence of carcinoma of the breast with microfilariasis
83. Microfilariae in association with neoplastic lesions: Report of five cases
84. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations
85. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana
86. Impact of single-dose ivermectin on community microfilaria load in bancroftian filariasis infection: Two years post treatment
87. Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India
88. Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: Evaluation of the potential for control at 12 months after treatment
89. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis
90. Lymphatic filariasis: Setting the scene for elimination
91. The global programme to eliminate lymphatic filariasis
92. Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment
93. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis
94. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis
95. Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro
96. Strong association of interleukin-6 and lipopolysaccharide-binding protein with severity of adverse reactions after diethylcarbamazine treatment of microfilaremic patients
97. Pharmacokinetics of UMF-078, a candidate antifilarial drug, in infected dogs
98. In vitro antifilarial activity of extracts of the medicinal plant Cardiospermum halicacabum against Brugia pahangi
99. Potential transition state phosphoramidate inhibitors of beta-tubulin as antifilarial agents
100. Anticancer agents suppressive for adult parasites of filariasis in Mongolian jirds
101. Elimination of lymphatic filariasis as a public health problem
102. The global lymphatic filariasis initiative
103. Community-directed treatment: The way forward to eliminating lymphatic filariasis as a public-health problem in Ghana
104. Global alliance launches plan to eliminate lymphatic filariasis
105. At last, the fight against lymphatic filariasis begins
106. Launching a lymphatic filariasis campaign in the Pacific Islands
107. Mapping of lymphatic filariasis in India
108. Mapping and estimating the population at risk from lymphatic filariasis in Africa
109. Bancroftian filariasis: Prevalence of antigenaemia and endemic normals in Orissa, India
110. Field evaluation of a rapid-format kit for the diagnosis of bancroftian filariasis in Egypt
111. Development of rapid assessment procedures for the delimitation of lymphatic filariasis-endemic areas
112. Comparative epidemiological studies on lymphatic filariasis, between tribal and non-tribal populations of Bankura district, West Bengal, India
113. Bancroftian filariasis in urban areas of Alagoas State, Northeast Brazil: Study in general population
114. Lymphatic filariasis in the Caribbean region: The opportunity for its elimination and certification
115. Lymphatic filariasis in the Philippines
116. EPIFIL: The development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis
117. The LYMFASIM simulation program for modeling lymphatic filariasis and its control
118. The impact of lymphatic filariasis on labour inputs in southern India: Results of a multi-site study
119. A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: Compliance with annual single-dose DEC mass treatment and some related operational aspects
120. Rational for morbidity management in bancroftian filariasis endemic areas
121. Controlling morbidity and interrupting transmission: Twin pillars of lymphatic filariasis elimination
122. Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina state, Brazil
123. Albendazole: A review of anthelmintic efficacy and safety in humans
124. Malnutrition and parasitic helminth infections
125. Ivermectin: Effectiveness in lymphatic filariasis
126. Global malnutrition